Lincoln Alternative Strategies LLC Reports 9.9% Ownership in XORTX Therapeutics Inc.

Lincoln Alternative Strategies LLC has filed a Schedule 13G indicating ownership of 572,470 common shares of XORTX Therapeutics Inc., representing 9.9% of the total outstanding shares. The filing, made under Rule 13d-1(c), certifies that the shares were not acquired for the purpose of influencing the control of the issuer. The filing was signed by Stephen Temes, Managing Member, on October 27, 2025. The beneficial ownership percentage is based on 5,784,688 shares of the Issuer's common stock issued and outstanding as of October 23, 2025.